REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Dermatologico Ivan Diazgranados I.P.S. S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Other Business Support Services | Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Instituto Dermatologico Ivan Diazgranados I.P.S. S.A.S. Profile Updated: October 02, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Instituto Dermatologico Ivan Diazgranados I.P.S. S.A.S. is a company in Colombia, with a head office in Barranquilla. It operates in the Ambulatory Health Care Services industry. It was first established on July 30, 2014. From the latest financial highlights, Instituto Dermatologico Ivan Diazgranados I.P.S. S.A.S. reported a net sales revenue increase of 10% in 2025. In, 2025, the company’s net profit margin decreased by 7.16%.

Headquarters
Cr 53 No 82 - 86 Lo 1
Barranquilla; Atlantico;

Contact Details: Purchase the Instituto Dermatologico Ivan Diazgranados I.P.S. S.A.S. report to view the information.

Basic Information
Registered Capital:
Purchase the Instituto Dermatologico Ivan Diazgranados I.P.S. S.A.S. report to view the information.
Financial Auditors:
Purchase the Instituto Dermatologico Ivan Diazgranados I.P.S. S.A.S. report to view the information.
Incorporation Date:
July 30, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Dermatologico Ivan Diazgranados I.P.S. S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
10%
Total Operating Revenue
10%
Operating Profit
-33.37%
EBITDA
-33.37%
Net Profit/Loss for the Period
-45%
Total Assets
0%
Total Equity
0%
Operating Profit Margin
-7.16%
Net Profit Margin
-7.16%
Return on Equity (ROE)
-16.17%
Debt / Equity
0%
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?